OSE Immunotherapeutics rallies on positive data for COVID-19 vaccine candidate

Ose Immunotherapeutics SA

30/11/2021 08:24

** Shares in OSE Immunotherapeutics  OSE.PA  jump 16% after
the biotechnology company announced the first positive results 
of its vaccine candidate against COVID-19, CoVepiT  urn:newsml:reuters.com:*:nASN001XVZ
    ** The immunological response was measured on the eight
healthy volunteers who received CoVepiT, showing the expected
efficacy at six weeks after the injection, the company said in a
statement
    ** The stock is up 60% year-to-date
    ** All eight analysts that cover the company rate it "strong
buy" or "buy" 



 (Reporting by Anait Miridzhanian)
 ((anait.miridzhanian@thomsonreuters.com))